Westra Therapeutics
AI-assisted brief. Numbers are deterministic — the model substituted them from the metric layer, it did not produce them. Every paragraph cites the sources that backed it. Hover any number to see its basis.
What the filings say
Westra Therapeutics reports revenue (fy) of $502M in its most recent annual filing. The company is classified as healthcare and listed on NASDAQ.mjqj-10k-fy26
Sell-side coverage is currently classified low coverage — the last analyst-coverage change on file is dated 2024-11-14.mjqj-10k-fy26
Computed from the filings
Reconstructed gross margin on a trailing basis comes to 37.7%. This is computed deterministically — the model did not produce the figure.mjqj-10k-fy26
What the desk would check next
The desk surfaced this name from the coverage-gap screen. The next checks worth running are independent triangulation of the disclosure that drove the surfacing, and a recheck of the customer or product concentration disclosed in the filing.mjqj-10k-fy26